Why is Vaxart, Inc. ?
- The company has declared positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD -30.28 MM
- NET SALES(Q) Highest at USD 72.41 MM
- OPERATING PROFIT MARGIN(Q) Highest at -7.91 %
- Over the past year, while the stock has generated a return of 10.88%, its profits have risen by 29.9%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
How much should you buy?
- Overall Portfolio exposure to Vaxart, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Vaxart, Inc. for you?
High Risk, Low Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at USD -30.28 MM
Highest at USD 72.41 MM
Highest at -7.91 %
Fallen by -25.33% (YoY
Highest at USD -5.73 MM
Highest at USD -8.12 MM
Highest at USD -8.14 MM
Highest at USD -0.04
Lowest at USD 55.06 MM
Lowest at 3.3 times
Here's what is working for Vaxart, Inc.
Net Sales (USD MM)
Operating Cash Flows (USD MM)
Net Sales (USD MM)
Operating Profit to Sales
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Raw Material Cost as a percentage of Sales
Here's what is not working for Vaxart, Inc.
Cash and Cash Equivalents
Debtors Turnover Ratio






